Clinical Trials

Classical hematologyGastrointestinal

417 enrolled

Gastrointestinal Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT07493304 2026-03-25

ROXI-CAT-II

Phase 3 Not yet recruiting

1,600 enrolled

Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT05198960 2026-03-20

AVAJAK

Classical hematologyMyeloid

1,308 enrolled

Hemorrhage, Polycythemia Vera, Thrombocythemia, Essential, Venous Thromboembolism, Primary Myelofibrosis

NCT05171049 2026-02-23

ASTER

1,150 enrolled

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT07005024 2026-02-05

DOAC

996 enrolled

Neoplasms, Venous Thromboembolism

NCT06861088 2026-02-02

CATIQ P3

Classical hematologyGastrointestinal

480 enrolled

Pancreatic Neoplasms, Pulmonary Embolism, Thromboembolism, Venous Thrombosis, Venous Thromboembolism

NCT02066454 2025-08-13

MYELAXAT

Classical hematologyPlasma cell

108 enrolled

Neoplasms, Plasma Cell, Venous Thromboembolism

NCT06580223 2025-07-18

Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma

Phase 3 Not yet recruiting

530 enrolled

Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

NCT05029063 2025-07-09

TRIM-Line

1,828 enrolled

Neoplasms, Venous Thromboembolism

NCT03045406 2025-06-24

CARAVAGGIO

1,170 enrolled 11 charts

Venous Thromboembolism

NCT01130025 2025-02-24

Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer

900 enrolled

Venous Thromboembolism

NCT01583218 2023-08-07

APEX

7,513 enrolled 18 charts 1 FDA

Venous Thromboembolism

NCT03090880 2022-11-17

PROVE

Classical hematologyThoracic

59 enrolled

Lung Neoplasms, Venous Thromboembolism

NCT04999176 2021-08-10

VALERIA

Phase 3 Unknown

440 enrolled

Neoplasms, Venous Thromboembolism

NCT02583191 2021-05-03

Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients

246 enrolled

Neoplasms, Venous Thromboembolism

NCT02585713 2020-08-04

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

300 enrolled 11 charts

Neoplasm Metastasis, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Intracranial Thrombosis, Venous Thromboembolism, Mesenteric Ischemia

NCT02555878 2019-09-12

A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

841 enrolled 24 charts

Neoplasms, Venous Thromboembolism

NCT02935530 2019-05-14

Thromboprophylaxis After Surgery for Gynecologic Malignancy in China

315 enrolled

Genital Neoplasms, Female, Venous Thromboembolism

NCT03240120 2019-04-17

A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism

Phase 3 Unknown

99 enrolled

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT02073682 2019-03-06

Cancer Venous Thromboembolism (VTE)

1,046 enrolled 24 charts

Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT02746185 2018-08-13

CASTA-DIVA

159 enrolled

Classical hematologyGastrointestinal

Neoplasms, Venous Thromboembolism

NCT01448746 2017-02-07

Optimal Prophylactic Method of Venous Thromboembolism (VTE)

Phase 3 Unknown

682 enrolled

Stomach Neoplasms, Venous Thromboembolism

NCT00876915 2015-11-24

PHACS

218 enrolled 20 charts

Pulmonary Embolism, Venous Thromboembolism

NCT01164046 2014-12-03

Longheva

56 enrolled

Neoplasms, Venous Thrombosis, Venous Thromboembolism

NCT00694382 2013-01-23

SAVE-ONCO

3,212 enrolled

Neoplasms, Venous Thromboembolism

NCT00219973 2010-04-28

CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)

526 enrolled

Hemorrhage, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT00723216 2010-04-05

Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery

151 enrolled

Abdominal Neoplasms, Venous Thromboembolism

NCT00135876 2007-04-27

Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients